1. Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway;
2. Department of Central Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China;
3. Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; and
4. Department of Hematology, St. Olavs University Hospital, Trondheim, Norway